MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$39,869K
Interest income
$3,106K
Loss before income
tax
-$39,869K
Total other income
(expense)
$1,580K
Change in fair value of
redeemable convertible...
$1,526K
Loss from operations
-$41,449K
Total operating
expenses
$41,449K
Research and development
$29,183K
General and
administrative
$12,266K
Back
Back
Income Statement
source: myfinsight.com
SpyGlass Pharma, Inc. (SGP)
SpyGlass Pharma, Inc. (SGP)